EYPT Eyepoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.

As of 06/24/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2005
Outstanding shares:  34,047,128
Average volume:  123,670
Market cap:   $256,715,345
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMGS7L1
Valuation   (See tab for details)
PE ratio:   -3.68
PB ratio:   1.48
PS ratio:   6.60
Return on equity:   -40.23%
Net income %:   -172.48%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy